Qualification of PET scanners for use in multicenter cancer clinical trials: The American College of Radiology Imaging Network experience

Journal of Nuclear Medicine

Volumn 50, Issue 7, 2009, Pages 1187-1193

  Scheuermann, Joshua S ^a,d   Saffer, Janet R ^a   Karp, Joel S ^a   Levering, Anthony M ^b   Siegel, Barry A ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b AMERICAN COLLEGE OF RADIOLOGY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HUP   (United States)

Author keywords

Multicenter clinical trials; PET quantification; Positron emission tomography; Scanner calibration; Standardized uptake value

Indexed keywords

CESIUM 137; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GERMANIUM 68; RADIOISOTOPE; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CALIBRATION; CAMERA; CANCER CENTER; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC IMAGING; HUMAN; LABORATORY; LIVER; MEASUREMENT ERROR; MEDICAL INSTRUMENTATION; MULTICENTER STUDY; OPERATOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOLOGY; RECORDING;

CLINICAL TRIALS AS TOPIC; EQUIPMENT FAILURE ANALYSIS; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; QUALITY ASSURANCE, HEALTH CARE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 67650088547     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.057455     Document Type: Article

References (11)

1. 18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. Eur J Cancer. 1999;35:1773-1782.
2. 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials. J Nucl Med. 2006;47:1059-1066.
3. ACRIN PET and PET/CT Scanner Qualification. Available at: http://www.acrin. org/CORELABS/PETCORELABORATORY/PETQUALIFICATION/tabid/485/ Default.aspx. Accessed April 23, 2009.
4. Triad. Available at: https://triad.acr.org/index.htm. Accessed April 23, 2009.
5. 18F-FDG standardized uptake values in normal tissues. J Nucl Med. 2004;45:784-788.
6. Ramos CD, Erdi YE, Gonen M, et al. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. Eur J Nucl Med. 2001;28:155-164.
7. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847-850.
8. Schomburg A, Bender H, Reichel C, et al. Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures. Eur J Nucl Med. 1996;23:571-574.
9. A calibration phantom for multi-center PET/CT studies of assessing response to therapy [abstract]. J Nucl Med. 2007;48(suppl 2):194P.
10. MacFarlane CR. ACR accreditation of nuclear medicine and PET imaging departments. J Nucl Med Technol. 2006;34:18-24.
11. Boellaard R, Hoekstra CJ, et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging. 2008;35:2320-2333.